Explore
Trendline
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Read More
Trendline
Innate Pharma Advances Immunotherapy Pipeline with Strategic Developments
Innate Pharma Advances Immunotherapy Pipeline with Strategic Developments
Read More
Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Read More
Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Read More
Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Read More
Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Read More
Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Read More
Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Read More
Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Read More
Trendline
Daiichi Sankyo Faces $850M Charge Amid Falling ADC Demand Forecast
Daiichi Sankyo Faces $850M Charge Amid Falling ADC Demand Forecast
Read More